SMTL ID : 4dce.1 (1 other biounit)

Crystal structure of human anaplastic lymphoma kinase in complex with a piperidine-carboxamide inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.03 Å

Oligo State

monomer

Ligands

1 x 0JF: (3S)-N-(4-methylbenzyl)-1-{2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}piperidine-3-carboxamide(Non-covalent)

0JF.1: 20 residues within 4Å: Chain A: L.45, V.53, A.71, K.73, E.90, I.94, F.97, I.102, V.103, L.119, E.120, M.122, A.123, G.125, D.126, L.179, I.191, G.192, D.193, F.194 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:A.71, A:I.94, A:I.94, A:I.94, A:F.97, A:I.102, A:V.103, A:L.179, A:F.194, A:F.194 Hydrogen bonds: A:M.122, A:M.122, A:D.126, A:D.126, A:G.192

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bryan, M.C. et al., Rapid development of piperidine carboxamides as potent and selective anaplastic lymphoma kinase inhibitors. J.Med.Chem. (2012)

Release Date

2012-02-08

Peptides

ALK tyrosine kinase receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ALK tyrosine kinase receptor

Related Entries With Identical Sequence